Successful combination of Alpha1H with chemotherapy
Alpha1H shows significant promise as a new and effective cancer drug with low toxicity in a clinical bladder cancer study. Now, a new, pre-clinical discovery shows that Alpha1H also improves the therapeutic efficacy of other cancer drugs. By combining Alpha1H with low doses of chemotherapeutic agents, an increase in treatment efficacy was observed. The findings suggest that that in addition to acting as a cancer drug on its own, Alpha1H may be used in combination with chemotherapy, to further improve therapeutic efficacy.This combination effect was demonstrated in a bladder cancer model in